Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response. (Record no. 21711053)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02242 a2200649 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516090020.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201504s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1592-8721 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.3324/haematol.2011.059246 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Jäger, Ulrich |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20150414 |
245 00 - TITLE STATEMENT | |
Title | Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Haematologica |
Date of publication, distribution, etc. | Sep 2012 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1431-8 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal, Murine-Derived |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bone Marrow |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Enzyme-Linked Immunosorbent Assay |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Follow-Up Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lymphoma, Follicular |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mitoxantrone |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Recurrence, Local |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pilot Projects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prognosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Remission Induction |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Rituximab |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sex Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Survival Rate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Tissue Distribution |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vidarabine |
General subdivision | administration & dosage |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fridrik, Michael |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zeitlinger, Markus |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Heintel, Daniel |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hopfinger, Georg |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Burgstaller, Sonja |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mannhalter, Christine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Oberaigner, Wilhelm |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Porpaczy, Edit |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Skrabs, Cathrin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Einberger, Christine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Drach, Johannes |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Raderer, Markus |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gaiger, Alexander |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Putman, Monique |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Greil, Richard |
773 0# - HOST ITEM ENTRY | |
Title | Haematologica |
Related parts | vol. 97 |
-- | no. 9 |
-- | p. 1431-8 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.3324/haematol.2011.059246">https://doi.org/10.3324/haematol.2011.059246</a> |
Public note | Available from publisher's website |
No items available.